Stimate® (desmopressin acetate) CSL Behring LLC 1

First Page		Document Content
Date: 2011-09-23 12:47:17 Haemophilia Desmopressin CSL Behring Neuroendocrinology Epistaxis Nasal administration Von Willebrand disease Haemophilia A Insufflation Medicine Health Routes of administration		Stimate® (desmopressin acetate) CSL Behring LLC 1 Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 106,93 KB Share Document on Facebook

	UPDATE: Baxalta’s BAX 855 Pivotal Data Published in Blood Shows Potential to Provide Strong Bleed Prevention with Twice Weekly Dosing for Patients with Hemophilia A • DocID: 1kAcN - View Document
	the Source mag a zine of the Pl a sma Protein Therapeut ic s Industry Plasma Protein TherapieS Summer DocID: 1fthz - View Document
	How to achieve full prophylaxis in young boys with severe haemophilia A: different regimens and their effect on early bleeding and venous access DocID: 1eIqY - View Document
	Les Ulis, 19th February 2009 "Position of LFB" following the discovery of a prion protein agent associated to variant Creutzfeldt-Jakob disease in the spleen of a deceased British haemophilia patient. DocID: 1eqqe - View Document
	Considerations in individualizing prophylaxis in patients with haemophilia A DocID: 1bptc - View Document